- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1743-422X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Lysosomotropic agents as HCV entry inhibitors ; volume:8 ; number:1 ; day:12 ; month:4 ; year:2011 ; pages:1-6 ; date:12.2011
Virology journal ; 8, Heft 1 (12.4.2011), 1-6, 12.2011
- Urheber
-
Ashfaq, Usman A.
- Beteiligte Personen und Organisationen
-
Javed, Tariq
Rehman, Sidra
Nawaz, Zafar
Riazuddin, Sheikh
SpringerLink (Online service)
- DOI
-
10.1186/1743-422X-8-163
- URN
-
urn:nbn:de:1111-201605015521
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ashfaq, Usman A.
- Javed, Tariq
- Rehman, Sidra
- Nawaz, Zafar
- Riazuddin, Sheikh
- SpringerLink (Online service)
Ähnliche Objekte (12)
Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies
New anti-HCV agents in the pipeline
Implications of hcv natural genetic diversity on HCV NS5B inhibitor NM283
Decoding hepatitis C virus entry : structural and functional determinants of the HCV entry factor CD81
Synthesis of HCV Protease Inhibitor MK-6325
Entry inhibitors in HIV therapy
Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents
Novel heteroaryl phosphonicdiamides PTPs inhibitors as anti-hyperglycemic agents
Selective inhibitors of cGMP phosphodiesterases as procognitive agents
Identification of serotonin 2A receptor as a novel HCV entry factor by a chemical biology strategy
Entry inhibitors as topical microbicides to prevent HIV-1 sexual transmission
Untersuchung visueller Aufmerksamkeitsparameter vor und nach einer Hepatitis C (HCV)-Therapie mit Direct Antiviral Agents bei HCV-monoinfizierten und HCV/HIV-koinfizierten Patienten
Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies
New anti-HCV agents in the pipeline
Implications of hcv natural genetic diversity on HCV NS5B inhibitor NM283
Decoding hepatitis C virus entry : structural and functional determinants of the HCV entry factor CD81
Synthesis of HCV Protease Inhibitor MK-6325
Entry inhibitors in HIV therapy
Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents
Novel heteroaryl phosphonicdiamides PTPs inhibitors as anti-hyperglycemic agents
Selective inhibitors of cGMP phosphodiesterases as procognitive agents
Identification of serotonin 2A receptor as a novel HCV entry factor by a chemical biology strategy
Entry inhibitors as topical microbicides to prevent HIV-1 sexual transmission
Untersuchung visueller Aufmerksamkeitsparameter vor und nach einer Hepatitis C (HCV)-Therapie mit Direct Antiviral Agents bei HCV-monoinfizierten und HCV/HIV-koinfizierten Patienten
Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies
New anti-HCV agents in the pipeline
Implications of hcv natural genetic diversity on HCV NS5B inhibitor NM283
Decoding hepatitis C virus entry : structural and functional determinants of the HCV entry factor CD81
Synthesis of HCV Protease Inhibitor MK-6325
Entry inhibitors in HIV therapy
Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents
Novel heteroaryl phosphonicdiamides PTPs inhibitors as anti-hyperglycemic agents
Selective inhibitors of cGMP phosphodiesterases as procognitive agents
Identification of serotonin 2A receptor as a novel HCV entry factor by a chemical biology strategy
Entry inhibitors as topical microbicides to prevent HIV-1 sexual transmission